Sarah Katharina Fehling

A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA

Katie Ewer, Tommy Rampling, Navin Venkatraman et al. · New England Journal of Medicine · 2015 · 356 citations · Full text

Veterinary Medicine, Infectious Disease Control, Infectious Diseases +14

Safety and immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine in adults and children in Lambaréné, Gabon: A phase I randomised trial

Sélidji Todagbé Agnandji, José F. Fernandes, Emmanuel B. Bache et al. · PLoS Medicine · 2017 · 68 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Longitudinal antibody and T cell responses in Ebola virus disease survivors and contacts: an observational cohort study

Ruth Thom, Thomas Tipton, Thomas Strecker et al. · The Lancet Infectious Diseases · 2020 · 47 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +11

Adjuvant formulated virus-like particles expressing native-like forms of the Lassa virus envelope surface glycoprotein are immunogenic and induce antibodies with broadly neutralizing activity

Helena Müller-Kräuter, Sarah Katharina Fehling, Jens Dorna et al. · npj Vaccines · 2020 · 36 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Pseudotyping of VSV with Ebola virus glycoprotein is superior to HIV-1 for the assessment of neutralising antibodies

Kimberley Steeds, Yper Hall, Gillian S. Slack et al. · Scientific Reports · 2020 · 30 citations · Full text

Life Sciences, Immunology, Infectious Diseases +15